Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b–2 dose-escalation study
Titel:
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b–2 dose-escalation study
Auteur:
Richardson, Paul G Jagannath, Sundar Moreau, Philippe Jakubowiak, Andrzej J Raab, Marc S Facon, Thierry Vij, Ravi White, Darrell Reece, Donna E Benboubker, Lotfi Zonder, Jeffrey Tsao, L Claire Anderson, Kenneth C Bleickardt, Eric Singhal, Anil K Lonial, Sagar